Corner Therapeutics

Corner Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts. With a team of 37 employees, the company focuses on developing innovative immunotherapies. Corner Therapeutics' flagship product is their dendritic cell hyperactivation (hDC) platform. This versatile technology has the potential to treat a wide range of cancers and infectious diseases. The platform works by inducing strong and long-lasting memory T cell responses, providing patients with robust and durable immunity. Corner Therapeutics differentiates itself through its commitment to developing accessible and patient-friendly immunotherapies. Their goal is to transform the standard of care by offering treatments that are affordable, rapid, and suitable even for complex diseases. Visit Corner Therapeutics online at cornertx.com to learn more about their groundbreaking work in immunotherapy.